share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股sec公告 ·  07/10 10:29
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 07/10/2024, with an aggregate market value of $1,111,135.20. The shares to be sold were acquired through restricted stock vesting on two separate dates, 02/17/2024 and 02/20/2024, as part of compensation from the issuer. Over the past three months, a total of 6,840 shares have been sold by the officer, generating gross proceeds of $3,181,238.40.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 07/10/2024, with an aggregate market value of $1,111,135.20. The shares to be sold were acquired through restricted stock vesting on two separate dates, 02/17/2024 and 02/20/2024, as part of compensation from the issuer. Over the past three months, a total of 6,840 shares have been sold by the officer, generating gross proceeds of $3,181,238.40.
Vertex Pharmaceuticals Inc.官員Carmen Bozic計劃於2024年07月10日賣出2,280股普通股,市值合計爲1,111,135.20美元。這些股份是通過兩個不同日期,即2024年02月17日和2024年02月20日的限制性股票釋放獲得的,作爲發行人的補償的一部分。過去三個月,該官員已經售出6,840股,總收益爲3,181,238.40美元。
Vertex Pharmaceuticals Inc.官員Carmen Bozic計劃於2024年07月10日賣出2,280股普通股,市值合計爲1,111,135.20美元。這些股份是通過兩個不同日期,即2024年02月17日和2024年02月20日的限制性股票釋放獲得的,作爲發行人的補償的一部分。過去三個月,該官員已經售出6,840股,總收益爲3,181,238.40美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息